BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Eli Lilly Expands Mounjaro Sales in India Amid Competitive Pricing Strategy
Eli Lilly Expands Mounjaro Sales in India Amid Competitive Pricing Strategy
21
2
BTCCSquare news:
Eli Lilly's shares surged 3.2% as the pharmaceutical giant announced the expansion of its Mounjaro GLP-1 weight loss drug in India, priced competitively against Novo Nordisk's Wegovy. The MOVE signals aggressive market penetration with starting doses at $160, undercutting Novo's $200-$300 range for smaller Wegovy doses.
Cantor Fitzgerald maintained a bullish stance despite lowering Lilly's price target to $825, citing underwhelming phase 3 data for orforglipron but emphasizing long-term growth potential. The analyst's confidence reflects broader Optimism around Lilly's capacity to capture emerging market demand.
By:
